Articles

Results 1 to 5 of 11


The Medical Device Regulation, COVID-19 and Brexit

European Union, United Kingdom - February 4 2021 Regulation 2020/561 (Regulation) was passed by the EU in April last year to take account of issues raised by the COVID-19 pandemic and to defer the…

Ian Tully, John E. Wyand

Pharmaceuticals Highlighted in the EU-UK Trade and Cooperation Agreement

European Union, United Kingdom - January 10 2021 The EU-UK Trade and Cooperation Agreement (the Agreement), announced just before Christmas, has now been agreed by the UK Parliament and EU Commission…

EU Pharmaceutical Strategy

European Union - December 1 2020 The European Commission President Ursula von der Leyen has put an emphasis on health policy since the beginning of her term, by promoting the…

William Downs, Christina Economides, Matthew Kirk, Francesco Liberatore, Wolfgang A. Maschek, Diarmuid Ryan, Ian Tully

Brexit: Phased Approach for Northern Ireland Protocol (NIP) for the Pharmaceuticals Sector

European Union, United Kingdom - November 12 2020 The UK Cabinet Office released a statement last Thursday 5th November 2020 that could provide some breathing space for the UK/EU pharmaceuticals…

UK End of Transition - Moves to Provide Clarity for Industry

European Union, United Kingdom - September 14 2020 The work of UK health and regulatory authorities has mainly been targeted on COVID-19 work over recent months but there has been an increasing focus…